BioFeyn

Pioneering advancements in nutrient, medicine, and vaccine delivery

San Francisco, United States · $250K raised

Employees
11–50
Total Funding
$250K
Last Round
$250K SeedOct 2020
Rounds
2

About

Biofeyn is a life sciences company pioneering advancements in nutrient, medicine, and vaccine delivery to improve food systems and sustainability. The company develops advanced biosensor and diagnostic platforms using proprietary surface chemistry. Co-founded by Timothy Johns, who previously established programs in planetary health at the World Bank mobilizing over $1 billion for innovation, and Marie-Christine Imbert, a molecular biologist and specialist in sustainable finance with a PhD from the MRC-LMB at Cambridge University. Biofeyn is focused on point-of-care and laboratory diagnostic applications with broad applications across food systems, aquaculture, and healthcare.

Summary

BioFeyn is an Advanced Materials company based in San Francisco, United States. It has raised $250K in total across 2 rounds, most recently a $250K Seed round in Oct 2020. Investors include Katapult.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundOct 2020

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies